What is an FDA Form 483?

What is an FDA Form 483?

FDA says: “An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.” It also says: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.”

Both sentences are quoted from FDA’s Form 483 FAQ, checked Nov 15, 2026.

What one looks like

The form’s top box names the FDA district office, the dates of inspection, the site’s FEI number, the person the form was issued to, the firm name and address, and the type of establishment. Below it come numbered observations: each starts with a one-line statement, then usually “Specifically,” and the details the investigator saw. FDA removes confidential business information and names before posting; markers such as (b)(4) or <Redacted B4> show where.

In this index

This index quotes 454 Form 483s FDA published for compounding pharmacies and outsourcing facilities with pages here, 2,714 observations in all, about 6.0 per form, from inspections ending Feb 22, 2013 to Sep 23, 2026. See every one, or the most common observations at 503B outsourcing facilities.

A recent example

The most recent 483 here, for LEESAR, INC., opens its first observation with: “: Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.”

Common questions

Is a Form 483 a finding that a firm broke the law?

No. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.”

Where does FDA publish Form 483s for compounders?

FDA links them, by facility, on its “Compounding: Inspections, Recalls, and other Actions” page and its registered outsourcing facility list, and lists published 483s by FEI number in the FDA Data Dashboard. This index reads all three.

Why are names missing?

FDA redacts personal names before posting, and this index also leaves out the names on the form’s cover and signature box (the person the form was issued to and the investigators). Firm names and addresses are shown.

Quoted from FDA’s Form 483 FAQ and FDA’s published 483s. This page explains a record type and is not legal advice. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.